Peritoneovenous shunt for pancreatic ascites

Waele, Boudewijn De; Spek, Peter van der; Devis, Ghislain

doi:10.1007/bf01296040

Digest Dis Sci

1987

DOI: 10.1007/bf01296040

|View full text |Cite

Peritoneovenous shunt for pancreatic ascites

Boudewijn De Waele¹,

Peter van der Spek²,

Ghislain Devis³

Abstract: A chronically ill patient with pancreatic ascites was successfully treated with a temporary LeVeen peritoneovenous shunt. This observation supports the use of a peritoneovenous shunt in the treatment of pancreatic ascites which is refractory to medical therapy and not amenable to major pancreatic surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1992

2003

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Pancreatic Ascites and Effusion

Parekh

Segal²

1992

Arch Surg

View full text Add to dashboard Cite

The possible risk factors for failure of medical therapy were examined in 23 patients with pancreatic ascites or effusion. The ascites or effusion resolved completely in 10 patients after a mean (+/- SEM) of 30 +/- 2 days of conventional medical treatment. In five patients in whom conventional medical therapy failed, the addition of an octreotide (SMS 201-995) analogue to the medical therapy led to a resolution of the ascites (three patients) or effusion (two patients). Six patients underwent surgery after failed medical therapy, one patient died while receiving conservative therapy, and one patient refused hospital treatment. Serum sodium and albumin levels were significantly lower, and the ratio of total fluid protein to total serum protein was significantly higher in the group that failed to heal in response to conventional medical therapy. Nine of 11 patients with mild to moderately severe chronic pancreatitis healed in response to conservative therapy. Only one of 10 patients with advanced pancreatitis healed in response to conventional medical therapy. Our results suggest that a selective surgical approach is warranted to treat pancreatic ascites and effusion. In patients with mild or moderately severe pancreatitis, medical therapy is recommended. Patients with advanced pancreatic disease should be selected for early surgery. Octreotide may be useful in the patient in whom surgery may be associated with a prohibitive morbidity or mortality.

show abstract

Pancreatic Ascites and Effusion

Parekh

Segal²

1992

Arch Surg

View full text Add to dashboard Cite

show abstract

Role of endoscopic retrograde pancreatography in pancreatic ascites

Kuo

1994

Digest Dis Sci

View full text Add to dashboard Cite

show abstract

Endoscopic treatment of pancreatic ascites

Kozarek

Jiranek

Traverso

1994

The American Journal of Surgery

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Peritoneovenous shunt for pancreatic ascites

Cited by 4 publications

References 9 publications

Pancreatic Ascites and Effusion

Pancreatic Ascites and Effusion

Role of endoscopic retrograde pancreatography in pancreatic ascites

Endoscopic treatment of pancreatic ascites

Contact Info

Product

Resources

About